telmisartan has been researched along with Marfan Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bernatchez, P; Donen, G; Tehrani, AY; Zhao, R | 1 |
| Goto, SN; Iwata, K; Takagi, H; Umemoto, T; Yamamoto, H | 1 |
| Ganburged, G; Moriyama, K; Suda, N | 1 |
3 other study(ies) available for telmisartan and Marfan Syndrome
| Article | Year |
|---|---|
Heterogenous improvements in endothelial function by sub-blood pressure lowering doses of ARBs result in major anti-aortic root remodeling effects.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzoates; Blood Pressure; Endothelium; Humans; Hypertension; Marfan Syndrome; Telmisartan | 2023 |
An evidence-based hypothesis for beneficial effects of telmisartan on Marfan syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Evidence-Based Medicine; Humans; Marfan Syndrome; Telmisartan | 2012 |
Effect of angiotensin II receptor blocker on experimental periodontitis in a mouse model of Marfan syndrome.
Topics: Alveolar Bone Loss; Angiotensin Receptor Antagonists; Animals; Bacteroidaceae Infections; Benzimidazoles; Benzoates; Bone Resorption; Disease Models, Animal; Inflammation; Interleukin-17; Male; Marfan Syndrome; Mice; Osteoclasts; Periodontitis; Porphyromonas gingivalis; Telmisartan; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2013 |